HUM vs KRYS · P/E 39, rev $117.76B vs P/E 46, rev $290.5M
Humana Inc (HUM) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the HUM and KRYS stock pages for the full models.
Not investment advice.